New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK/PD model

VKORC1型 华法林 加药 CYP2C9 药效学 非金属 医学 人口 药理学 药代动力学 抗凝剂 药物遗传学 内科学 基因型 生物 遗传学 环境卫生 细胞色素P450 新陈代谢 心房颤动 基因
作者
Karine Rodríguez-Fernández,Gledys Reynaldo Fernández,Stephanie Reyes-González,Camila de las Barreras,Leyanis Rodríguez-Vera,Cornelis P. Vlaar,Jean‐Christophe M. Monbaliu,Torsten Stelzer,Jorge Duconge,Víctor Mangas‐Sanjuán
出处
期刊:Biomedicine & Pharmacotherapy [Elsevier BV]
卷期号:170: 115977-115977
标识
DOI:10.1016/j.biopha.2023.115977
摘要

Warfarin, an oral anticoagulant, has been used for decades to prevent thromboembolic events. The complex interplay between CYP2C9 and VKORC1 genotypes on warfarin PK and PD properties is not fully understood in special sub-groups of patients. This study aimed to externally validate a population pharmacokinetic/pharmacodynamic (PK/PD) model for the effect of warfarin on international normalized ratio (INR) and to evaluate optimal dosing strategies based on the selected covariates in Caribbean Hispanic patients. INR, and CYP2C9 and VKORC1 genotypes from 138 patients were used to develop a population PK/PD model in NONMEM. The structural definition of a previously published PD model for INR was implemented. A numerical evaluation of the parameter-covariate relationship was performed. Simulations were conducted to determine optimal dosing strategies for each genotype combinations, focusing on achieving therapeutic INR levels. Findings revealed elevated IC50 for G/G, G/A, and A/A VKORC1 haplotypes (11.76, 10.49, and 9.22 mg/L, respectively), in this population compared to previous reports. The model-guided dosing analysis recommended daily warfarin doses of 3-5 mg for most genotypes to maintain desired INR levels, although subjects with combination of CYP2C9 and VKORC1 genotypes * 2/* 2-, * 2/* 3- and * 2/* 5-A/A would require only 1 mg daily. This research underscores the potential of population PK/PD modeling to inform personalized warfarin dosing in populations typically underrepresented in clinical studies, potentially leading to improved treatment outcomes and patient safety. By integrating genetic factors and clinical data, this approach could pave the way for more effective and tailored anticoagulation therapy in diverse patient groups.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
chase发布了新的文献求助10
1秒前
陈苗完成签到 ,获得积分20
3秒前
Prime完成签到 ,获得积分10
4秒前
4秒前
陈苗关注了科研通微信公众号
8秒前
中世纪托尼完成签到 ,获得积分10
8秒前
言草西完成签到,获得积分10
10秒前
Nienie发布了新的文献求助10
10秒前
汉堡包应助沙糖桔采纳,获得10
12秒前
SCINEXUS应助S2639采纳,获得10
12秒前
SCINEXUS应助S2639采纳,获得50
12秒前
大个应助闪闪如松采纳,获得10
15秒前
15秒前
15秒前
Airbus完成签到 ,获得积分10
16秒前
奥特超曼应助luchong采纳,获得10
17秒前
陈曦发布了新的文献求助10
18秒前
18秒前
19秒前
thth完成签到,获得积分10
19秒前
20秒前
顾涵山发布了新的文献求助20
21秒前
dyce发布了新的文献求助10
22秒前
沙糖桔完成签到,获得积分10
23秒前
Lost完成签到,获得积分10
24秒前
在水一方应助biubiudididi采纳,获得10
25秒前
123发布了新的文献求助10
25秒前
一晃儿完成签到,获得积分10
25秒前
25秒前
Lucas应助Nienie采纳,获得10
26秒前
北夏发布了新的文献求助10
26秒前
lzx发布了新的文献求助10
27秒前
27秒前
Hina发布了新的文献求助10
28秒前
28秒前
28秒前
29秒前
乂贰ZERO叁发布了新的文献求助10
29秒前
美丽星期五完成签到,获得积分10
31秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989660
求助须知:如何正确求助?哪些是违规求助? 3531826
关于积分的说明 11255082
捐赠科研通 3270447
什么是DOI,文献DOI怎么找? 1804981
邀请新用户注册赠送积分活动 882136
科研通“疑难数据库(出版商)”最低求助积分说明 809176